StreetAlpha
13F holdings · Q3 2026

Empery Asset Management

New York, NY · files as Empery Asset Management, LP
Know the moment Empery Asset Management filesYou follow Empery Asset Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1469336

Empery Asset Management reported 32 stocks worth $81.4M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are XFOR (34.6%), EMPD (17.9%) and OTLK (15.0%). Compared with Q2 2026, the fund opened new positions in OTLK, PYXS and AMLX, added to XFOR, EMPD and CLRB, trimmed NGEN, TNYA and CLNN and sold out of ANVS, AMC and VENU.

Latest filing: what Empery Asset Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
8 new4 added9 trimmed8 sold outBought about $38.1M · sold about $21.1M
New 8
See all 8 →
Added 4
Trimmed 9
See all 9 →
Sold out 8
See all 8 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$81.4M−5.9% vs last quarter · $96.5M including options
Stocks held328 new · 8 sold out
Top 5 weight78.4%very concentrated
Turnover73%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 4 qtrsHeld
1
XFOR
X4 Pharmaceuticals Inc
$28.2M34.6%9.7M+2.8M (+40%)4 of 4
2
EMPD
Empery Digital Inc
$14.5M17.9%4.8M+1.9M (+65%)4 of 4
3
OTLK
Outlook Therapeutics Inc
$12.2M15.0%21.2MNew position1 of 4
4
NGEN
Nervgen Pharma Corp
$6.3M7.8%3.3M−691K (−17%)2 of 4
5
CLEANCORE SOLUTIONS INC
$2.6M3.2%20MNew position1 of 4
6
PYXS
Pyxis Oncology Inc
$2.3M2.9%1MNew position1 of 4
7
CLRB
Cellectar Biosciences Inc
$1.8M2.2%955K+766K (+404%)2 of 4
8
AMLX
Amylyx Pharmaceuticals Inc
$1.7M2.1%60KNew position1 of 4
9
DYAI
Dyadic Intl Inc Del
$1.5M1.8%3.3MNew position1 of 4
10
TNYA
Tenaya Therapeutics Inc
$1.3M1.6%2.1M−1.7M (−45%)4 of 4
🔒 22 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
ANVS
Annovis Bio Inc C
$4.5M2.4M
AMC
Amc Entmt Hldgs Inc
$3.3M1.7M
VENU
Venu Hldg Corp
$1.2M513K
SCYX
Scynexis Inc
$515K126K
RNTX
Rein Therapeutics Inc
$386K371K

🔒 Free account: see all 8.

Options

valued at the underlying shares
StockTypeValueSharesChange
MRNA
Moderna Inc
Put$14.1M73K+73,300
CLDX
Celldex Therapeutics Inc New
Call$972K30K+30,000

Reported value

last 4 quarters
$113MQ4 '25
$83MQ1 '26
$86.5MQ2 '26
$81.4MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Empery Asset Management 13F FAQ

What does Empery Asset Management own?

Empery Asset Management reported 32 stocks worth $81.4M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are XFOR (34.6%), EMPD (17.9%) and OTLK (15.0%). The table above lists every position in the filing (the top 10 without an account).

What did Empery Asset Management buy and sell in Q3 2026?

Compared with Q2 2026: 8 new positions, 4 added to, 9 trimmed and 8 sold out. New positions include OTLK, PYXS and AMLX. It sold all of ANVS, AMC and VENU.

When will Empery Asset Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Empery Asset Management's portfolio worth?

The Q3 2026 filing reports $81.4M in US stocks ($96.5M including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.